Tears Again advanced Liposome Spray
Useful in MGD
FOR IMMEDIATE RELEASE
Richmond, TX (December 18, 2009) — OCuSOFT, Inc., a leader in ocular surface disease is pleased to announce the introduction of Tears Again advanced Liposome Spray, a unique eyelid spray which has been reported to benefit patients suffering from Meibomian Gland Dysfunction.
Dry, scratchy, irritated eyes? The problem may not be the eyes but rather the eyelids. Real relief is available with Tears Again advanced Liposome Spray—a cool, refreshing spray which contains vital nutrients including antioxidants and vitamins A, C, and E. Applied directly to eyelids with the eyes closed, this patented formula contains microscopic liposomes, which enhance absorption and lubricate to protect against moisture loss. Liposomes are microscopic molecules that have been used for years in cosmetics and drug delivery.
Recently launched at the International Vision Expo West Conference (Las Vegas, October 2009), Tears Again advanced Liposome Spray drew crowds of curious attendees to the OCuSOFT booth for a spray demonstration. Almost immediately, participants noticed a significant difference in the comfort of their eyes and eyelids.
Paul Karpecki, OD, FAAO, reports “Dry Eye sufferers (particularly those with lipid deficiency) and Meibomian Gland Dysfunction patients do very well with Tears Again [advanced] Liposome Spray. Individuals that have difficulty instilling eye-drops should also be considered.”
Because daily lid hygiene is important for healthy eyes, Tears Again advanced Liposome Spray is ideal to use in conjunction with OCuSOFT Lid Scrub eyelid cleansers to remove oil and debris from the eyelid that can contribute to eye irritation.
OCuSOFT, Inc. has made a conscious decision to limit retail availability in order to assist doctors in the promotion of their practice. Special discount pricing is available to doctors for dispensing from their office or optical. Alternatively, patients may order direct (no shipping charges) at www.ocusoft.com.
For more information or a trial evaluation, please contact:
OCuSOFT, Inc.
Phone: 800-233-5469
Email: press@ocusoft.com